Glicalzide 80 mg + Metformin 500 mg Sustained Release Tablets

Pack: 10 tablets/strip

DOSAGE: B.I.D

Mode of Action :

Glicalzide

• Second generation sulphonylurea
• Improves defective insulin secretion and reverse insulin resistance
• Decrease FBG, PPG, HbAlc levels

Metformin

• Decrease liver glucose production
• Suppresses hepatic gluconeogenesis

Journal of applied Pharmaceutical science Gliclazide possess the properties of preventing the progression of diabetic retinopathy and of controlling blood glucose levels. Gliclazide reduces platelet adhesion, aggregation and hyperactivity and increases fibrinolysis hence useful in halting the progression of diabetic Microangiopath

Indication:

• Uncontrolled Type 2 diabetes mellitus
• NIDDM with/without Obesity

NIDDM with Vascular Complications